Compounds of formula (I): in which R1, R2, R3 R4, and R5, U, X, Y, and Z are as defined herein. Also disclosed is use of these compounds, alone or in combination with other active agents, to treat hepatitis C virus infection.
申请公布号
US2009111757(A1)
申请公布日期
2009.04.30
申请号
US20080254439
申请日期
2008.10.20
申请人
TAIGEN BIOTECHNOLOGY CO., LTD.
发明人
LIN CHU-CHUNG;LEE KUANG-YUAN;LIU CHEN-FU;LO PIN;LIU YO-CHIN;HAN YUEH-CHIANG;KING CHI-HSIN RICHARD
